MARIJUANA & DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
MARIJUANA & DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
批准号:
3208158
负责人:
ELIOT L GARDNER
金额:
$20.59万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-04-01 至 1992-11-30
关键词:
brain mapping cannabinoids centrally acting drug dopamine dopamine receptor electrochemistry experimental brain lesion inhibitor /antagonist laboratory rat limbic system microinjections neuropeptide receptor neurotoxins neurotransmitter metabolism opioid receptor psychopharmacology reinforcer self stimulation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of the proposed research is to gain further insights into
marijuana's action on brain reward circuits and on dopamine (DA) and
enkephalinergic mechanisms involved in marijuana, derive part of their
abuse liability from neuropharmacological facilitation of brain reward
circuits. During the period of previous NIDA grant support for this work,
we demonstrated that delta-9-tetrahydrocannabinol (delta9-THC), the major
psychoactive ingredient in marijuana, does the following: (1) lowers
direct brain reward thresholds in the medial forebrain bundle, in a rat
strain-specific fashion, (2) enhances presynaptic release of known to
support brain reward, and (3) interacts noncompetitively with endogenous
brain delta and Mu opioid receptors but not Kappa receptors, and the opioid
receptor interaction of a series of cannabinoid analogs correlates crudely
but not precisely with psychoactive potency. The general aim of the
presently proposed work is to carry forward and extend all these findings.
The specific aims are to (1) extend ours studies of delta9-THC and analogs
on direct brain reward as measured by electrical intracranial self-
stimulation in laboratory rats; (2) extend our studies of the effects of
delta9-THC and analogs on DA release, in forebrain DA loci supporting
direct brain reward, as measured by both in vivo voltammetric
electrochemistry and in vivo intracranial microdialysis; and (3) extend our
studies of the interaction of delta9-THC and selected analogs with
endogenous brain opioid receptors, as measured by receptor binding and
quantitative autoradiography. A major aim running throughout is to learn
the specific locus in the brain of the already-demonstrated delta9-TCH
effects. This proposal addresses specific research needs stipulated in the
NIDA Marijuana Research Announcement and in NIDA Grant Announcement DA-87-
24 ("...studies are needed concerning the neurophysiological effects of
marijuana, including potential sites and mechanisms of action.."
"...research areas of particular importance include...brain reward
mechanisms"). By adding to our understanding of marijuana's effects on one
of the presumptive principal neurophysiological substrates of drug abuse
liability, these studies should yield additional insight into fundamental
brain mechanisms underlying marijuana's abuse potential, and to treatment
possibilities for marijuana abuse. The health relatedness is clear, given
that marijuana is the most widely used illicit drug in the United States,
and given the evidence for health consequences of chronic marijuana abuse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALCOHOL REWARD AND BRAIN DOPAMINE--PHARMACO-MODULATIONS
-
批准号:3443564
-
项目类别:
-
资助金额:$11.61万
-
财政年份:1992
-
负责人:ELIOT L GARDNER
-
依托单位:
ALCOHOL REWARD AND BRAIN DOPAMINE--PHARMACO-MODULATIONS
-
批准号:2045789
-
项目类别:
-
资助金额:$11.56万
-
财政年份:1992
-
负责人:ELIOT L GARDNER
-
依托单位:
CLOZAPIN--CHOLINERGIC BASIS OF MESOLIMBIC SPECIFICITY
-
批准号:3428725
-
项目类别:
-
资助金额:$4.66万
-
财政年份:1988
-
负责人:ELIOT L GARDNER
-
依托单位:
MARIJUANA & DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
-
批准号:2116776
-
项目类别:
-
资助金额:$18.82万
-
财政年份:1984
-
负责人:ELIOT L GARDNER
-
依托单位:
MARIJUANA AND DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
-
批准号:3208159
-
项目类别:
-
资助金额:$15.52万
-
财政年份:1984
-
负责人:ELIOT L GARDNER
-
依托单位:
MARIJUANA AND DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
-
批准号:3208160
-
项目类别:
-
资助金额:$14.55万
-
财政年份:1984
-
负责人:ELIOT L GARDNER
-
依托单位:
Basic brain mechanisms underlying drug addiction, craving, and relapse
-
批准号:7593286
-
项目类别:
-
资助金额:$37.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models
-
批准号:7733810
-
项目类别:
-
资助金额:$38.96万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Glutamatergic compounds for treating drug addiction: Preclinical models
-
批准号:7733812
-
项目类别:
-
资助金额:$31.17万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Glutamatergic compounds for treating drug addiction: Pre
-
批准号:7321124
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
GABAergic compounds-treating drug addiction: Preclinical
-
批准号:7149329
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction
-
批准号:7593285
-
项目类别:
-
资助金额:$37.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
GABAergic compounds for treating drug addiction: Preclinical models
-
批准号:7733811
-
项目类别:
-
资助金额:$31.17万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Dopamine D3 receptor antagonists-treating drug addiction
-
批准号:7149328
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Basic brain mechanisms underlying drug addiction, cravin
-
批准号:7321126
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Glutamatergic compounds for treating drug addiction
-
批准号:7149330
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Slow-onset long-acting dopamine transport inhibitors
-
批准号:7149331
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Slow-onset long-acting dopamine transport inhibitors for
-
批准号:7321125
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models
-
批准号:7593282
-
项目类别:
-
资助金额:$46.26万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction
-
批准号:7733813
-
项目类别:
-
资助金额:$31.17万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
海外基金